Treatment devices and methods

Patent metadata

Field	Value
Publication number	US-10258405-B2
Application number	US-201715595305-A
Country	US
Kind code	B2
Filing date	May 15, 2017
Priority date	Jun 23, 2008
Publication date	Apr 16, 2019
Grant date	Apr 16, 2019

Abstract

A tissue treatment selection device that has at least one treatment delivery member, a delivery setting circuit that is coupled to the treatment delivery member that is adapted to be deployed into tissue to deliver therapeutic energy to a target tissue zone, and the processing circuit is operable to set treatment parameters in the delivery setting circuit that is operable to set treatment parameters in the delivery setting circuit. The processing circuit is operable to transmit a test signal through the deployed treatment delivery member and to determine deployment status. The treatment selection device has a processing circuit adapted to send a message to a display device that indicates that the deployed treatment delivery member has been determined to be compensable and contains a suggested change in the treatment parameters. Also presented herein is a method of treating a tissue of a patient using the treatment delivery device.

First claim

The invention claimed is:

1. A tissue treatment apparatus, comprising:
a treatment source, the treatment source configured to generate irreversible electroporation (IRE) for delivery to a target tissue zone;
a treatment delivery device comprising at least a first treatment delivery member and a second treatment delivery member, each to be deployed into tissue to deliver the irreversible electroporation to the target tissue zone; and
a processing circuit programmed to:
set a plurality of treatment parameters;
transmit a test signal through at least one of the deployed first treatment delivery member and the deployed second treatment delivery member; and
determine whether the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment based upon a depth of the deployed first treatment delivery member or the deployed second treatment delivery member, and a distance between the deployed first treatment delivery member and the deployed second treatment delivery member; and
determine a change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member without withdrawing the deployed first treatment delivery member or deployed second treatment delivery member from the target tissue zone.

2. The tissue treatment apparatus of claim 1 , wherein the processing circuit is programmed to automatically change the at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member.

3. The tissue treatment apparatus of claim 1 , wherein the processing circuit is programmed to send a message to a display device that indicates that the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment.

4. The tissue treatment apparatus of claim 1 , wherein the processing circuit is programmed to send a message to a display device that indicates the determined change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member.

5. The tissue treatment apparatus of claim 1 , wherein the processing circuit is further programmed to determine the distance between the deployed first treatment delivery member and the deployed second treatment delivery member based upon an impedence measurement from the test signal.

6. A tissue treatment apparatus, comprising:
a treatment source, the treatment source configured to generate irreversible electroporation (IRE) for delivery to a target tissue zone;
a treatment delivery device comprising a longitudinal shaft and at least two treatment delivery members to be deployed into tissue to deliver irreversible electroporation to the target tissue zone, wherein the at least two treatment delivery members are deployed radially outwardly from the longitudinal shaft of the treatment delivery device into the target tissue zone; and
a processing circuit programmed to:
set a plurality treatment parameters;

transmit at least one test signal through the at least two deployed treatment delivery members; and
determine that at least one of the least two deployed treatment delivery members has been mis-deployed prior to treatment based upon a depth of the least two treatment delivery members, and a distance between the at least two treatment delivery members; and determine a change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of at least one of the least two deployed treatment delivery members without withdrawing the at least two treatment delivery members from the target tissue zone.

7. The tissue treatment apparatus of claim 6 , wherein:
the processing circuit is further programmed to determine the distance between the at least two treatment delivery members based upon an impedence measurement from the test signal.

Assignees

• Angiodynamics Inc

Inventors

• Bhargav Shaily
• Blau David A
• Lovewell James G
• Pearson Robert M

Classifications

• A61B2018/1467

  using more than two electrodes on a single probe · CPC title

• A61B2018/147

  Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue · CPC title

• A61B18/12 Primary

  by passing a current through the tissue to be heated, e.g. high-frequency current · CPC title

• A61B2018/1273

  including multiple generators in one device · CPC title

• A61B18/1206 Primary

  Generators therefor · CPC title